AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,687 Cr | ₹1,285 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,687 Cr |
| Mar2025 | ₹1,285 Cr |
| Mar2024 | ₹895 Cr |
| Mar2023 | ₹1,139 Cr |
| Mar2022 | ₹647 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,687 Cr | 31.28 | |
| Mar2025 | ₹1,285 Cr | 43.53 | |
| Mar2024 | ₹895 Cr | -21.42 | |
| Mar2023 | ₹1,139 Cr | 75.98 | |
| Mar2022 | ₹647 Cr | - | |
Compare Total Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹40,959.7 Cr | -0.9% | 11.4% | 31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.9% |
11.4% |
31% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses